Suzanne Kinsky

Dr. Suzanne Kinsky


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2017 in Harm Reduction Journal
Verified
Journal Article
Open access
PDF file
MHMary Hawk
Mary Hawk
TMTravis Moore
Travis Moore
JEJames E. Egan
James E. Egan
SFStuart Fisk
Stuart Fisk
MFM. Reuel Friedman
M. Reuel Friedman
SKSuzanne Kinsky
Suzanne Kinsky
Harm reduction refers to interventions aimed at reducing the negative effects of health behaviors without necessarily extinguishing the problematic health behaviors completely. The vast majority of the harm reduction literature focuses on the harms of drug use and on specific harm reduction strategies, such as syringe exchange, rather than on the harm reduction philosophy as a whole. Given that a harm reduction approach can address other risk behaviors that often occur alongside drug use and that harm reduction principles have been applied to harms such as sex work, eating disorders, and tobacco use, a natural evolution of the harm reduction philosophy is to extend it to other health risk behaviors and to a broader healthcare audience. Building on the extant literature, we used data from in-depth qualitative interviews with 23 patients and 17 staff members from an HIV clinic in the USA to describe harm reduction principles for use in healthcare settings. We defined six principles of harm reduction and generalized them for use in healthcare settings with patients beyond those who use illicit substances. The principles include humanism, pragmatism, individualism, autonomy, incrementalism, and accountability without termination. For each of these principles, we present a definition, a description of how healthcare providers can deliver interventions informed by the principle, and examples of how each principle may be applied in the healthcare setting. This paper is one of the firsts to provide a comprehensive set of principles for universal harm reduction as a conceptual approach for healthcare provision. Applying harm reduction principles in healthcare settings may improve clinical care outcomes given that the quality of the provider-patient relationship is known to impact health outcomes and treatment adherence. Harm reduction can be a universal precaution applied to all individuals regardless of their disclosure of negative health behaviors, given that health behaviors are not binary or linear but operate along a continuum based on a variety of individual and social determinants.

1 February 2015 in AIDS Patient Care and STDs
Verified
Journal Article
Open access
JAJudith D. Auerbach
Judith D. Auerbach
SKSuzanne Kinsky
Suzanne Kinsky
GBGina Brown
Gina Brown
VCVignetta Charles
Vignetta Charles
Although the Food and Drug Administration (FDA) approved oral Truvada for pre-exposure prophylaxis (PrEP) for women at risk of HIV infection in the US in July 2012, and the Centers for Disease Control and Prevention (CDC) issued guidance for clinicians to provide PrEP to women “at substantial risk of HIV acquisition” in May 2014, there remain no clinical trial data on efficacy among US women, and there is a dearth of research on knowledge, attitudes, and likelihood of use of PrEP among them. We conducted a qualitative focus group (FG) study with 144 at-risk women in six US cities between July and September 2013, including locations in the Southern US, where HIV infections among women are most prevalent. FG questions elicited awareness of PrEP, attitudes about administration and uptake, and barriers to and facilitators of use. Women expressed anger at the fact that they had not heard of PrEP prior to the study, but once informed most found it attractive. PrEP was seen as additional, not substitute protection to condoms, and participants suggested several dissemination strategies to meet the diverse needs of women. Key barriers to PrEP uptake included distrust of the medical system, stigma, and cost. Findings suggest that US women view PrEP as an important prevention option, assuming side effects and the cost to the consumer are minimal, the efficacy of the drug is reasonable, and PrEP is delivered by trusted providers in trusted venues.

1 September 2019 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
SKSuzanne Kinsky
Suzanne Kinsky
PHPatricia R. Houck
Patricia R. Houck
KMKristin Mayes
Kristin Mayes
DLDavid Loveland
David Loveland
DDDennis Daley
Dennis Daley
JSJames M. Schuster
James M. Schuster

1 September 2015 in LGBT Health
Verified
Journal Article
Closed access
TMTravis Moore
Travis Moore
SKSuzanne Kinsky
Suzanne Kinsky
AHAmy L. Herrick
Amy L. Herrick
RSRon D. Stall
Ron D. Stall
JBJose Bauermeister
Jose Bauermeister
Purpose: Syndemics, or the co-occurrence and interaction of health problems, have been examined extensively among young men who have sex with men, but their existence remain unexamined, to our knowledge, among sexual-minority (i.e., lesbian, gay, and bisexual) women. Thus, we investigated if syndemics were present among young sexual-minority women, and if sexual-orientation discrimination was an independent variable of syndemic production. Methods: A total of 467 sexual-minority women between the ages of 18 and 24 completed a cross-sectional online survey regarding their substance use, mental health, sexual behaviors, height, weight, and experiences of discrimination. We used structural equation modeling to investigate the presence of syndemics and their relationship to sexual-orientation discrimination. Results: Heavy episodic drinking, marijuana use, ecstasy use, hallucinogen use, depressive symptoms, multiple sexual partners, and history of sexually transmitted infections (STIs) comprised syndemics in this population (chi-square=24.989, P=.201; comparative fit index [CFI]=0.946; root mean square error of approximation [RMSEA]=0.023). Sexual-orientation discrimination is significantly and positively associated with the latent syndemic variable (unstandardized coefficient=0.095, P<.05), and this model fit the data well (chi-square=33.558, P=.059; CFI=0.914; RMSEA=0.029). The reverse causal model showed syndemics is not an independent variable of sexual-orientation discrimination (unstandardized coefficient=0.602, P>.05). Conclusions: Syndemics appear to be present and associated with sexual-orientation discrimination among young sexual-minority women. Interventions aimed at reducing discrimination or increasing healthy coping may help reduce substance use, depressive symptoms, and sexual risk behaviors in this population.

12 February 2015 in AIDS and Behavior
Verified
Journal Article
Closed access
PDF file
TTThe Positive Charge Intervention Team
The Positive Charge Intervention Team
CMCathy Maulsby
Cathy Maulsby
VCVignetta Charles
Vignetta Charles
SKSuzanne Kinsky
Suzanne Kinsky
MRMaura Riordan
Maura Riordan
DHDavid Holtgrave
David Holtgrave

1 May 2016 in American Journal of Public Health
Verified
Journal Article
Closed access
RSRon Stall
Ron Stall
DMDerrick D. Matthews
Derrick D. Matthews
MFM. Reuel Friedman
M. Reuel Friedman
SKSuzanne Kinsky
Suzanne Kinsky
JEJames E. Egan
James E. Egan
NMNina Markovic
Nina Markovic